Equities Research Analysts’ Updated EPS Estimates for November 24th (ADSK, ADUR, AEIS, AMBA, ANAB, ANET, ARGX, ASC, ASPI, AVAV)

Equities Research Analysts’ updated eps estimates for Monday, November 24th:

Autodesk (NASDAQ:ADSK) had its buy rating reaffirmed by analysts at Rosenblatt Securities. Rosenblatt Securities currently has a $355.00 target price on the stock.

Aduro Clean Technologies (NASDAQ:ADUR) had its buy rating reaffirmed by analysts at D. Boral Capital. D. Boral Capital currently has a $46.00 target price on the stock.

Advanced Energy Industries (NASDAQ:AEIS) was downgraded by analysts at Wall Street Zen from a strong-buy rating to a buy rating.

Ambarella (NASDAQ:AMBA) had its buy rating reaffirmed by analysts at Rosenblatt Securities. The firm currently has a $100.00 price target on the stock.

AnaptysBio (NASDAQ:ANAB) had its outperform rating reaffirmed by analysts at Wedbush. They currently have a $50.00 price target on the stock.

Arista Networks (NYSE:ANET) had its neutral rating reissued by analysts at Rosenblatt Securities. They currently have a $140.00 target price on the stock.

argenex (NASDAQ:ARGX) had its peer perform rating reaffirmed by analysts at Wolfe Research.

ASOS (LON:ASC) had its hold rating reaffirmed by analysts at Panmure Gordon. They currently have a GBX 350 price target on the stock.

ASP Isotopes (NASDAQ:ASPI) had its buy rating reaffirmed by analysts at Canaccord Genuity Group Inc.. The firm currently has a $11.00 price target on the stock.

AeroVironment (NASDAQ:AVAV) had its buy rating reiterated by analysts at BTIG Research. They currently have a $415.00 target price on the stock.

Babcock International Group (LON:BAB) had its buy rating reissued by analysts at Jefferies Financial Group Inc.. The firm currently has a GBX 1,400 target price on the stock.

Brandywine Realty Trust (NYSE:BDN) had its underweight rating reiterated by analysts at JPMorgan Chase & Co..

Booking (NASDAQ:BKNG) had its buy rating reissued by analysts at BTIG Research. BTIG Research currently has a $6,250.00 price target on the stock.

Cerillion (LON:CER) had its buy rating reaffirmed by analysts at Berenberg Bank. They currently have a GBX 2,125 target price on the stock.

Cerillion (LON:CER) had its buy rating reiterated by analysts at Peel Hunt. They currently have a GBX 2,020 target price on the stock.

Cerillion (LON:CER) had its buy rating reissued by analysts at Panmure Gordon. The firm currently has a GBX 2,000 target price on the stock.

Co-Diagnostics (NASDAQ:CODX) had its neutral rating reissued by analysts at HC Wainwright.

Charles River Associates (NASDAQ:CRAI) had its outperform rating reaffirmed by analysts at Barrington Research. Barrington Research currently has a $239.00 price target on the stock.

Corteva (NYSE:CTVA) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.

Day One Biopharmaceuticals (NASDAQ:DAWN) had its buy rating reissued by analysts at Needham & Company LLC. They currently have a $16.00 price target on the stock.

Day One Biopharmaceuticals (NASDAQ:DAWN) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $25.00 target price on the stock.

DNOW (NYSE:DNOW) had its buy rating reiterated by analysts at Stifel Nicolaus. Stifel Nicolaus currently has a $18.00 price target on the stock.

Alpha Tau Medical (NASDAQ:DRTS) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $9.00 target price on the stock.

Enlivex Therapeutics (NASDAQ:ENLV) had its hold rating reaffirmed by analysts at D. Boral Capital.

Extreme Networks (NASDAQ:EXTR) had its buy rating reiterated by analysts at Needham & Company LLC. Needham & Company LLC currently has a $24.00 price target on the stock.

Frontdoor (NASDAQ:FTDR) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.

H. B. Fuller (NYSE:FUL) was downgraded by analysts at Wall Street Zen from a buy rating to a hold rating.

Galecto (NASDAQ:GLTO) was downgraded by analysts at Wall Street Zen from a hold rating to a sell rating.

Greencore Group (LON:GNC) had its outperform rating reissued by analysts at Royal Bank Of Canada. The firm currently has a GBX 300 target price on the stock.

Gladstone Commercial (NASDAQ:GOOD) had its neutral rating reiterated by analysts at B. Riley. They currently have a $11.00 price target on the stock, down from their previous price target of $12.00.

Hillman Solutions (NASDAQ:HLMN) had its buy rating reiterated by analysts at Canaccord Genuity Group Inc.. The firm currently has a $15.00 price target on the stock.

Hammerson (LON:HMSO) had its buy rating reaffirmed by analysts at Panmure Gordon. Panmure Gordon currently has a GBX 330 target price on the stock.

Harmony Biosciences (NASDAQ:HRMY) had its buy rating reaffirmed by analysts at Needham & Company LLC. Needham & Company LLC currently has a $42.00 target price on the stock.

Harmony Biosciences (NASDAQ:HRMY) had its buy rating reiterated by analysts at HC Wainwright. HC Wainwright currently has a $55.00 target price on the stock.

Immatics (NASDAQ:IMTX) had its buy rating reaffirmed by analysts at Chardan Capital. They currently have a $25.00 target price on the stock.

JD Sports Fashion (LON:JD) was downgraded by analysts at Shore Capital to a hold rating. Shore Capital currently has GBX 85 price target on the stock.

Jet2 (LON:JET2) had its outperform rating reiterated by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a GBX 2,150 price target on the stock.

Johnson Matthey (LON:JMAT) had its buy rating reissued by analysts at Panmure Gordon. They currently have a GBX 2,370 target price on the stock.

Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) had its buy rating reaffirmed by analysts at HC Wainwright. The firm currently has a $9.00 price target on the stock.

Lumentum (NASDAQ:LITE) had its buy rating reaffirmed by analysts at Rosenblatt Securities. They currently have a $280.00 price target on the stock.

Liquidity Services (NASDAQ:LQDT) had its outperform rating reaffirmed by analysts at Barrington Research. Barrington Research currently has a $40.00 price target on the stock.

Masimo (NASDAQ:MASI) had its buy rating reissued by analysts at BTIG Research. They currently have a $198.00 price target on the stock.

NeuroSense Therapeutics (NASDAQ:NRSN) had its buy rating reaffirmed by analysts at D. Boral Capital. D. Boral Capital currently has a $14.00 target price on the stock.

Novo Nordisk A/S (NYSE:NVO) was downgraded by analysts at HSBC Holdings plc from a buy rating to a hold rating.

NWF Group (LON:NWF) had its buy rating reissued by analysts at Panmure Gordon. The firm currently has a GBX 283 target price on the stock.

On the Beach Group (LON:OTB) had its buy rating reissued by analysts at Panmure Gordon. Panmure Gordon currently has a GBX 300 target price on the stock.

PureCycle Technologies (NASDAQ:PCT) had its hold rating reissued by analysts at TD Cowen. TD Cowen currently has a $9.00 price target on the stock, down from their previous price target of $16.00.

Personal Group (LON:PGH) had its hold rating reaffirmed by analysts at Peel Hunt. The firm currently has a GBX 630 price target on the stock.

Rainbow Rare Earths (LON:RBW) had its buy rating reissued by analysts at Berenberg Bank. The firm currently has a GBX 33 price target on the stock.

M&C Saatchi (LON:SAA) was downgraded by analysts at Peel Hunt to a hold rating. They currently have GBX 115 price target on the stock, down from their previous price target of GBX 185.

S4 Capital (LON:SFOR) had its hold rating reissued by analysts at Peel Hunt. They currently have a GBX 25 target price on the stock.

VinFast Auto (NASDAQ:VFS) had its outperform rating reaffirmed by analysts at Wedbush. They currently have a $6.00 price target on the stock.

XPS Pensions Group (LON:XPS) had its outperform rating reiterated by analysts at Royal Bank Of Canada. They currently have a GBX 465 target price on the stock.

Block (NYSE:XYZ) had its buy rating reaffirmed by analysts at Needham & Company LLC. They currently have a $80.00 target price on the stock.